1st Quarter - Report
MCDERMOTT WILL & SCHULTE LLP for ISIS PHARMACEUTICALS
Client
Income
—
Expenses
—
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Health care and patent legislation to ensure the protection of life-saving medical research and development.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID DUANE RANSOM | Member) |
| STEPHEN M RYAN | Deputy Counsel, President's Commission on |
| KAREN SEALANDER | — |
Medical/Disease Research/Clinical Labs MED
Health care and patent legislation to ensure the protection of life-saving medical research and development.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID DUANE RANSOM | Member). |
| STEPHEN M RYAN | Organized Crime. |
| KAREN SEALANDER | — |
Pharmacy PHA
Health care and patent legislation to ensure the protection of life-saving medical research and development.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID DUANE RANSOM | Member). |
| STEPHEN M RYAN | Organized Crime. |
| KAREN SEALANDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.